Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Harvard University
- Nanyang Technological University
- Zintellect
- City of Hope
- National University of Singapore
- University of Maryland, Baltimore
- Indiana University
- Northeastern University
- University of Birmingham
- University of Michigan
- University of Oslo
- Dana-Farber Cancer Institute (DFCI)
- Florida International University
- King's College London
- SciLifeLab
- UNIVERSITY OF MELBOURNE
- University of British Columbia
- University of Colorado
- Università degli Studi di Padova
- ADELAIDE UNIVERSITY
- Aarhus University
- Center for Biologics Evaluation and Research (CBER)
- Cold Spring Harbor Laboratory
- Delaware State University
- Margaret M Redfield
- Marquette University
- NTNU - Norwegian University of Science and Technology
- National Center for Toxicological Research (NCTR)
- Queen's University Belfast;
- Stazione Zoologica Anton Dohrn
- The University of Queensland
- UNIVERSITY OF HELSINKI
- University of Bergen
- University of California
- University of California, Los Angeles
- University of Cincinnati
- University of Leeds
- University of London
- University of Michigan (U-M)
- University of Michigan - Ann Arbor
- University of North Carolina at Charlotte
- University of Oxford
- University of Texas at Austin
- Université de Strasbourg
- Weill Cornell Medicine - Chandwani Laboratory
- eQuest
- 36 more »
- « less
-
Field
-
interpret multi-omics, imaging, and functional analyses, including RNA sequencing and single-cell transcriptomic datasets. • Prepare manuscripts, research reports, grant applications, and present research
-
hypertension. Mechanistic studies include hemodynamics, cardiac and pulmonary histology and cardiac and pulmonary tissue discovery omics (RNA, proteomics, metabolomics, spatial omics and bioinformatics) from
-
complementary experimental approaches, including advanced imaging, dual-species sequencing and custom library preparation, RNA-based therapeutics, and genome editing in both mammalian and bacterial systems
-
strong publication record, will be prioritized. Prior experience in working with primary fibroblasts, 3D organoids and/or RNA biology is a plus. Qualifications Qualifications: Education Required: Ph.D
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more
-
: RNA extraction, RT-PCR, in situ hybridization, and gene expression alteration (silencing, knock-down, transfection).Bioinformatics & imaging: transcriptomic analysis of candidate genes and confocal
-
. Hands-on experience in performing primary human- and cancer- cell culture, complex cell-based assay development and screening technologies (including multicolor flow cytometry, RNA-seq, library
-
blotting and immunoprecipitation Drug response assay, determination of IC50 etc. Analysis of big datasets (e.g. RNA-sequencing) Working with animals (not essential, but preferential). Ability to assess
-
analyses for methods such as flow cytometry, cell culture/stimulations, and RNA sequencing (bulk, single-cell, spatial) may also be available based on your interests. Research endeavors are intrinsically